Evidence map›Paper›PMID 32296123›Full record

ArticleEuropean journal of clinical nutrition2020

Prevalence of sarcopenia and malnutrition during acute exacerbation of COPD and after 6 months recovery.

L Perrot, A Greil, Y Boirie, N Farigon, A Mulliez, F Costes, D Caillaud

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

L PerrotCHU Clermont-Ferrand, Service de Pneumologie, Clermont-Ferrand, France. loic.perrot@imm.fr.ORCID http://orcid.org/0000-0002-4647-5066
A GreilCHU Clermont-Ferrand, Service de Pneumologie, Clermont-Ferrand, France.
Y BoirieCHU Clermont-Ferrand, Service de Nutrition Clinique, Clermont-Ferrand, France.
N FarigonCHU Clermont-Ferrand, Service de Nutrition Clinique, Clermont-Ferrand, France.
A MulliezCHU Clermont-Ferrand, Délégation à la Recherche Clinique et l'Innovation, Clermont-Ferrand, France.
F CostesUniversité Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.
D CaillaudCHU Clermont-Ferrand, Service de Pneumologie, Clermont-Ferrand, France.
Centre Hospitalier Universitaire de Clermont-Ferrand · FRUniversité Clermont Auvergne · FRInstitut Génétique, Reproduction et Développement · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesSarcopenia defined by the association of skeletal muscle mass depletion and a decreased physical performance is underdiagnosed in chronic obstructive pulmonary disease (COPD) patients. The objective was to assess prevalence of sarcopenia and malnutrition in hospitalized COPD patients during an acute exacerbation, after 6 months follow-up and the 1-year survival. SUBJECTS/

methodsHospitalized COPD patients were recruited for the assessment of body composition, handgrip strength, respiratory function, and maximal inspiratory and expiratory pressures (MIP and MEP), during hospitalization and 6 months later. Sarcopenia was defined according to the criteria of the European Working Group on Sarcopenia in Older Adults, malnutrition was defined according to French criteria 2007. Survival data were collected 12 months after hospitalization.

resultsWe analyzed data from 54 patients, aged 68 ± 9 years and BMI 26.9 ± 7.8 kg/m

conclusionsSarcopenia in COPD patients is highly prevalent during and after recovery of an acute exacerbation, exposing to lower survival. A multimodal management is required to treat sarcopenia and improve prognosis.

Indexed as

MalnutritionPulmonary Disease, Chronic ObstructiveSarcopeniaAgedCross-Sectional StudiesHand StrengthHumansPrevalence

Identifiers

PMID32296123
OpenAlexW3016638847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.